Core Viewpoint - Danish biotech Zealand Pharma is accelerating the development and expanding research of its experimental obesity drug candidates to differentiate them in a competitive market [1] Company Summary - Zealand Pharma aims to enhance its position in the obesity treatment sector by speeding up the development of its drug candidates [1] - The company is focusing on research expansion to create unique offerings in the obesity drug market [1] Industry Summary - The obesity drug market is becoming increasingly competitive, prompting companies like Zealand Pharma to innovate and differentiate their products [1]